NOVITIUM PHARMA FDA Approval ANDA 216393

ANDA 216393

NOVITIUM PHARMA

FDA Drug Application

Application #216393

Application Sponsors

ANDA 216393NOVITIUM PHARMA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL100MG0TRIMETHOPRIMTRIMETHOPRIM

FDA Submissions

UNKNOWN; ORIG1AP2022-10-28STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

NOVITIUM PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216393
            [companyName] => NOVITIUM PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRIMETHOPRIM","activeIngredients":"TRIMETHOPRIM","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/28\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-10-28
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.